<DOC>
	<DOCNO>NCT02972385</DOCNO>
	<brief_summary>Warfarin commonly use blood thinner treat prevent blood clot . It important take right dose warfarin much increase risk bleed little increase risk blood clot . This patient closely monitor especially begin warfarin therapy . When clinician prescribe warfarin , consider different factor patient 's age , body size , diet , medication interact warfarin . Certain gene also find affect warfarin dose . Individuals variation gene , help explain patient need high dose others require less . These factor use good predict patient 's warfarin dose requirement . However , prediction create base Caucasian population may accurate predict safe warfarin dose patient Caucasian . This study aim identify new genetic variation affect warfarin dose Hispanic Latino population try good predict Hispanic Latino patient 's warfarin dose requirement .</brief_summary>
	<brief_title>Pharmacogenomics Warfarin Hispanics Latinos</brief_title>
	<detailed_description>If patient willing hear study , routine clinical care , one patient 's provider approach patient meet study criterion participation study . Study personnel approach potential participant unless permission give patient 's provider . If patient would like participate study , study personnel discuss detail study person patient 's routine clinical care visit . There also flyer available post distribution potential participant . Participants consent study ask provide cheek swab mouthwash sample provide buccal cell DNA extraction . If patient receive blood draw regular clinical appointment , participant ask blood sample 15 milliliter . Genomic DNA isolate genotyping patient plasma sample also store . Linear regression use test association SNPs therapeutic warfarin dose use algorithms derive International Warfarin Pharmacogenomics Consortium . The primary phenotype ( weekly stable warfarin dose ) transform square root . SNPs variable associate warfarin dose assess univariate analysis enter stepwise linear regression determine adjust association dose requirement use R2 . Quality control procedure include deviation Hardy-Weinberg Equilibrium , SNP sample exclusion base call rate . Ancestry-informative marker ( AIM ) analysis perform estimate ancestry individual .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>At least 18 year age Ability give inform consent Therapeutic INR least 2 consecutive clinic visit Selfidentifies Hispanic Latino Less 18 year old Unable give inform consent Severe hepatic impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>warfarin</keyword>
	<keyword>blood clotting</keyword>
</DOC>